Sickle Cell Disease 101. Objectives. What is SCD? 4/20/2016. Discuss the pathophysiology & genetics of Sickle Cell Disease (SCD).

Size: px
Start display at page:

Download "Sickle Cell Disease 101. Objectives. What is SCD? 4/20/2016. Discuss the pathophysiology & genetics of Sickle Cell Disease (SCD)."

Transcription

1 Sickle Cell Disease 101 Jennifer Young, RN, MS, CPNP-AC Sickle Cell & Thalassemia Nurse Practitioner Nationwide Children s Hospital Objectives Discuss the pathophysiology & genetics of Sickle Cell Disease (SCD). Discuss the common complications of SCD. Briefly discuss sickle cell trait. What is SCD? Disorder of the red blood cells. Normal red blood cells are disc shaped and very pliable. Sickle cells are sickle shaped, rigid and break very easily. Cold Fever/infection Dehydration Hypoxia (low oxygen saturation) Acidosis Sickle cells don t live as long as normal red blood cells which leads to anemia. 1

2 Who Gets SCD? An inherited autosomal recessive disorder. One affected gene is received from each parent. Each parent must have either sickle cell trait or sickle cell disease to have a child with sickle cell disease. Geographical Pattern Africa North and South America The Mediterranean Middle East India and Pakistan The Caribbean Incidence & Etiology 72,000 Americans have sickle cell disease Affects 1:500 African-Americans 1:1,000-1,4000 Hispanic-Americans #1 Inherited disorder in the United States Ohio Newborn Screening Ohio screens for 32 genetic diseases at birth. Since 1991 abnormal hemoglobin screening has been included. Ohio Department of Health is notified of abnormal hemoglobin screens. ODH then notifies Newborn Screening Coordinator. Primary Care Provider referral is necessary to be seen in clinic. Some Primary Care Providers choose to manage SCD on their own. 2

3 PATHOPHYSIOLOGY CAC GTG GTG CAC GAC TGA GGA CTC CTG ACT CCT GAG valine histidine leucine threonine proline glutmaic acid CTC GAG glutamic acid CAC GTG GTG GAC TGA GGA CAC CAC CTG ACT CCT GTG valine histidine leucine threonine proline valine CTC GAG glutamic acid Single amino acid substitution: valine replaces glutamic acid on the 6 th position of the ß chain Sickle HGB What Are The Odds? If both parents have sickle cell trait: 25% chance with each pregnancy of having a child with disease What Are The Odds? If one parent has sickle cell trait & one parent has sickle cell disease: 50% chance with each pregnancy of having a child with sickle cell disease. 3

4 SCD Genotypes Four common types with varying degrees of severity and associated complications. Hgb SS Hgb SBeta 0 Thalassemia Hgb SC Hgb SBeta + Thalassemia Not all children will have the same experience with pain and/or complications, in part due to different types of disease. Common complications Anemia Pain Infection Acute Chest Syndrome Stroke Splenic Sequestration Some are life threatening while others are life altering Manifestations of Sickle Cell 4

5 Anemia Caused by chronic destruction of red blood cells & shorter red cell lifespan. Degree of anemia will vary based on type of sickle cell. Important to know the patient s baseline! Anemia may worsen during times of: Infection Splenomegaly MAY be seen during times of painful episode. Degree of Anemia Normal Hgb g/dl Hgb SS/Hgb SBeta0Thal 6-9 g/dl Hgb SC 9-12 g/dl Hgb S Beta + Thal g/dl Reticulocyte count Indication of the bone marrow response to anemia Normal (outside of newborn period) 0.5-2% Typically increased in SCD Bilirubin likely increased in SCD due to release with red blood cell destruction. Pain Caused by clumping of sickle cells. Log jam effect. Can occur in any part of the body. Common sites: Bones Lungs Abdomen Joints Hands/feet- Dactylits common in infants and toddlers. Swollen hands/feet that are painful to the touch 5

6 Pain Prevention Warm clothing- layers Dry off after swimming Hydration!!! Reduce stress Prompt treatment of illness/injury Educating patients/families on prevention is key Outpatient Pain Management Early, aggressive management hours of scheduled oral regimen ibuprofen 10mg/kg/dose Q6 hours oral opioid- Hydrocodone w/ acetaminophen (Norco/Lortab) 0.15mg/kg/dose Q4-hours Oxycodone mg/kg/dose Q4-6 hours No longer using Tylenol with codeine Doses may need adjusting due to tolerance Inpatient Pain Management IV fluid hydration IV opioid via PCA pump Morphine or Dilaudid most commonly Consider home opioid regimen when determining opioid dosing Anti-inflammatory medications. Toradol 0.5mg/kg x1dose followed by ibuprofen Q6 hours. Non-pharmacological therapies: Heat Psychology Massage Therapy 6

7 Infection Children with SCD can become seriously ill very quickly due to infection. #2 cause of death in children with sickle cell!! Infection Prevention Oral penicillin twice daily (until 5 yrs of age) Most children died in infancy prior to penicillin. Pneumococcal and Meningococcal vaccines. Annual influenza vaccine. Can develop secondary complications from the flu; therefore, broad spectrum antibiotics necessary. Acute Chest Bacteremia Risk of Infection Splenic dysfunction: encapsulated organisms. Auto infarct spleen by 5-6 years of age. Neutrophil migration abnormality Vascular endothelial abnormality: increased adhesion Infection Management Temperature of o or higher is treated as emergent Requires evaluation in clinic or Emergency Department. CBC, retic, blood cx, Ceftriaxone CXR necessary if respiratory symptoms/chest pain are present. Can likely be managed at home after evaluation but may require inpatient management. T 103, WBC 30,000, noncompliance 7

8 Acute Chest Syndrome (ACS) Most common cause of acute death in children and adults with SCD. 10% hospital mortality in adults 2nd most common cause of hospitalization in patients with sickle cell disease. #1 most common complication of surgery and anesthesia in patients with SCD Definition of ACS Definition: new infiltrate on CXR + Fever Chest Pain Hypoxia Other respiratory symptoms. Causes: Fat embolism Atelectasis Infection Pathophysiology of ACS 1. Regional hypoxia/lung injury occurs causing cells to sickle d/t inability to reoxygenate. 2. Sticky/inflexible sickled cells clog up microvasculature of the lungs. 4. As a result further sickling, Occlusion, and pulmonary infarction occurs which leads to increased hypoxia and lung injury. 3. Sickled cells stick to the endothelium of the lungs causing inflammation & vascular stasis. 8

9 Signs & Symptoms of ACS Rapid respirations Nasal flaring Grunting Retractions Wheezing Low oxygen saturation Shortness of breath Fever may or may not present Management of ACS Inpatient management to monitor for respiratory deterioration Can see rapid decline in the first 48 hours. Continuous pulse oximetry & AGGRESSIVE incentive spirometry & pulmonary toilet. Incentive spirometry is the only intervention proven to prevent ACS. Oxygen therapy as needed to keep sats >92% in order to break the cycle of hypoxia. Management of ACS Antibiotics Ceftriaxone Streptococcus pneumoniae and Hemophilus influenza Azithromycin Mycoplasma pneumoniae and Chlamydia pneumoniae Bronchodilators- Albuterol Transfusion therapy Effective in improving oxygenation & lowering sickle hemoglobin concentration. Improvement in clinical condition with transfusion therapy has been well documented. 9

10 Stroke About 10% of children with sickle cell disease will have a stroke. More common in children with Hgb SS. Peak age 3-10 years of age. 30% of children with SCD have silent strokes Ischemic insult Signs & Symptoms of Stroke Altered mental status Severe headache Sudden onset of vomiting Visual changes Slurred or altered speech Weakness on one side of the body Personality changes Seizures Unable to arouse or coma Stroke Prevention & Management Prevention: Annual screening with Transcranial Doppler (TCD) ultrasound to identify children at highest risk Treatment: Early intervention is key!! Exchange transfusion (apheresis) Emergently then Q3-5 weeks indefinitely Decreases sickle concentration to prevent repeat stroke Long-term management of complications Weakness or altered mobility if present Academic challenges 10

11 Splenic Sequestration Vaso-occlusion of the spleen Most often in infants & toddlers with Hgb SS disease May be presents in setting of a febrile illness Can occur in older children Acute can be an EMERGENCY! Hgb and platelet count drops Chronic splenomegaly can lead to chronic thrombocytopenia. Splenic Sequestration Management Education for early detection is essential How to assess spleen size. s/s of worsening anemia Acute management: Monitoring for worsening sequestration leading to worsening anemia Can be done inpatient or outpatient depending on case and severity May require PRBC transfusion Splenic Sequestration Management Parental and Provider monitoring for recurrent/worsening sequestration Close outpatient follow-up to monitor CBC, retic and spleen size Chronic transfusion therapy may be necessary. May require splenectomy. If greater than 5 yrs of age patient will need to restart Penicillin VK 250mg BID life-long Increased risk of bacteremia in asplenia Pre-splenectomy immunizations are required. Encapsulated organisms 11

12 Disease Modifying Agents Hydroxyurea Daily oral medication given to: Initiate/increase fetal hemoglobin (hgb F) productive Decrease blood viscosity by decreasing white cells & platelets. NIH recommendation: Hgb SS & S Beta 0 Thalassemia 9 months of age and older. Close follow-up is necessary Adherence assessment Medication tolerance Monitoring for side effects neutropenia, thrombocytopenia, elevated renal and/or liver function studies Dose titration What About A Cure? Bone Marrow Transplant (BMT) Risk/Benefit Ratio to be considered Matched sibling donor HLA typing Cord Blood Banking 15-20% chance that a sibling would be match Matched unrelated donor match through National Marrow Donor Program Some difficulty in finding a match Close follow-up is necessary Sickle Cell Trait Definition: A hereditary condition in which an individual inherits one normal gene for hemoglobin (A) and one abnormal gene for hemoglobin (S) Prevalence: There are 1 million to 3 million Americans with sickle cell trait. 1:12 African Americans 12

13 Complications of Sickle Cell Trait Typically asymptomatic Complications may development in extreme conditions Physical exhaustion Athletic conditioning Military Management of Sickle Cell Trait Education- Family and patient education of trait status Family education with Newborn Screening Counselor in early childhood. Patient education: Prevent extreme conditions Inheritance pattern of SCD and risk of having a child with SCD Questions? 13

Sickle Cell Disease. Edward Malters, MD

Sickle Cell Disease. Edward Malters, MD Sickle Cell Disease Edward Malters, MD Introduction Vaso-occlusive phenomena and hemolysis are the clinical hallmarks of Sickle Cell Disease (SCD) Inherited disorder due to homozygosity for the abnormal

More information

Sickle cell disease. Fareed Omar 10 March 2018

Sickle cell disease. Fareed Omar 10 March 2018 Sickle cell disease Fareed Omar 10 March 2018 Physiology Haemoglobin structure HbA2: 2α and 2δ chains (2-3%) HbF: 2α and 2γ chains (

More information

Atlantic Provinces Pediatric Hematology Oncology Network Réseau d Oncologie et Hématologie Pédiatrique des Provinces Atlantiques

Atlantic Provinces Pediatric Hematology Oncology Network Réseau d Oncologie et Hématologie Pédiatrique des Provinces Atlantiques Atlantic Provinces Pediatric Hematology Oncology Network Réseau d Oncologie et Hématologie Pédiatrique des Provinces Atlantiques 5850/5980 University Avenue, PO Box 9700 Halifax, NS, B3K 6R8 1.902.470.7429

More information

Sickle Cell Disease and impact on the society

Sickle Cell Disease and impact on the society Sickle Cell Disease and impact on the society Professor Z.A.Jeremiah Ph.D, FRCPath (London) Professor of Haematology and Blood Transfusion Science Niger Delta University, Wilberforce Island Outline What

More information

Anemia s. Troy Lund MSMS PhD MD

Anemia s. Troy Lund MSMS PhD MD Anemia s Troy Lund MSMS PhD MD lundx072@umn.edu Hemoglobinopathy/Anemia IOM take home points. 1. How do we identify the condtion? Smear, CBC Solubility Test (SCD) 2. How does it present clincally? 3. How

More information

Managing Emergencies

Managing Emergencies Managing Emergencies Richard Ward, MSc, MRCP, FRCPath Director, Red Blood Cell Disorders Program, UHN Assistant Professor, Hematology, University of Toronto Chair, Canadian Hemoglobinopathy Association

More information

Congenital Haemoglobinopathies

Congenital Haemoglobinopathies Congenital Haemoglobinopathies L. DEDEKEN, MD H O P I T A L U N I V E R S I T A I R E D E S E N F A N T S R E I N E F A B I O L A U N I V E R S I T E L I B R E DE B R U X E L L E S Red Blood Cell Disorders

More information

Division of General Internal Medicine and Geriatrics Hospital Medicine 2014

Division of General Internal Medicine and Geriatrics Hospital Medicine 2014 Division of General Internal Medicine and Geriatrics Hospital Medicine 2014 Objectives Understand workup of acute pain crisis Identify key aspects of management of acute pain crisis in sickle cell patients

More information

Sickle Cell Anemia. Sickle cell anemia is an inherited disorder of the blood which occurs when just one base pair substitution

Sickle Cell Anemia. Sickle cell anemia is an inherited disorder of the blood which occurs when just one base pair substitution Rose Farrington and Rachel Nash BIOL 362 Lab M. Bulgarella Genetic Diseases 10/14/2008 Sickle Cell Anemia Introduction Sickle cell anemia is an inherited disorder of the blood which occurs when just one

More information

DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES

DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES DISCLAIMER: This Clinical Practice Guideline (CPG) generally describes a recommended course of treatment for patients with the identified health

More information

Putting some hematology into Pediatric Hematology/Oncology: a review of Hemophilia and Sickle Cell Disease in the Pediatric Patient

Putting some hematology into Pediatric Hematology/Oncology: a review of Hemophilia and Sickle Cell Disease in the Pediatric Patient Putting some hematology into Pediatric Hematology/Oncology: a review of Hemophilia and Sickle Cell Disease in the Pediatric Patient Kristina Haley, DO March 10, 2012 Jovita Reyes Memorial Pediatric Hematology/Oncology

More information

HbSC disease is it different and how should we manage it? David Rees Department of Paediatric Haematology, King s College Hospital, London

HbSC disease is it different and how should we manage it? David Rees Department of Paediatric Haematology, King s College Hospital, London HbSC disease is it different and how should we manage it? David Rees Department of Paediatric Haematology, King s College Hospital, London Different types of sickle cell disesease Severe sickle cell disease

More information

SICKLE CELL BROCHURE

SICKLE CELL BROCHURE SICKLE CELL BROCHURE SICKLE CELL DIESEASE According to CDC, Sickle cell disease (SCD) is a group of inherited red blood cell disorders. Healthy red blood cells are round and SCD C -shaped farm tool called

More information

How to Write a Life Care Plan for a Child with Hemoglobinopathy

How to Write a Life Care Plan for a Child with Hemoglobinopathy How to Write a Life Care Plan for a Child with Hemoglobinopathy Tamar Fleischer, BSN, MSN, CNLCP & Mona Yudkoff, RN, MPH, CRRN, CNLCP BalaCare Solutions March 2018 St. Peterburg, Florida What is Hemoglobinopathy?

More information

Seventh Visit Posttest

Seventh Visit Posttest Test code 07D Patient s name: Seventh Visit Posttest Patient s birth date: Your name and relationship to patient: Today s date: Please mark only one answer for each of the following questions: 1. Which

More information

Guideline for the Management of Acute Chest Syndrome in Children with Sickle Cell Disease

Guideline for the Management of Acute Chest Syndrome in Children with Sickle Cell Disease Guideline for the Management of Acute Chest Syndrome in Children with Sickle Cell Disease Definition Acute chest syndrome (ACS) is defined as an acute illness characterized by fever and/or respiratory

More information

World-Wide Distribution of Hemoglobin S. Geographic distribution of hemoglobin S in the world

World-Wide Distribution of Hemoglobin S. Geographic distribution of hemoglobin S in the world Sickle Cell Disease Gerald M. Woods, MD Professor of Pediatrics Division Director, Hematology/Oncology/BMT Director of Sickle Cell Program Children s Mercy Hospitals and Clinics Disclaimer Member of DSMB

More information

Care of School Age Children with Sickle Cell Disease. Lesley Ann Owen, RN, MSN Vanderbilt Children s Hospital Pediatric Sickle Cell Clinic

Care of School Age Children with Sickle Cell Disease. Lesley Ann Owen, RN, MSN Vanderbilt Children s Hospital Pediatric Sickle Cell Clinic Care of School Age Children with Sickle Cell Disease Lesley Ann Owen, RN, MSN Vanderbilt Children s Hospital Pediatric Sickle Cell Clinic Sickle cell disease around the world African Americans Latin Americans

More information

Hydroxyurea. for Sickle Cell Disease. A Guide for Starting Treatment. Hydroxyurea is a medicine proven to prevent pain from sickle cell disease.

Hydroxyurea. for Sickle Cell Disease. A Guide for Starting Treatment. Hydroxyurea is a medicine proven to prevent pain from sickle cell disease. Hydroxyurea for Sickle Cell Disease A Guide for Starting Treatment Hydroxyurea is a medicine proven to prevent pain from sickle cell disease. This handbook was created to help answer common questions about

More information

The Child with a Hematologic Alteration

The Child with a Hematologic Alteration 47 The Child with a Hematologic Alteration HELPFUL HINT Review the anatomy and physiology of the hematologic system in an anatomy and physiology textbook. MATCHING KEY TERMS Match the term with the correct

More information

Hemolytic anemias (2 of 2)

Hemolytic anemias (2 of 2) Hemolytic anemias (2 of 2) Sickle Cell Anemia The most common familial hemolytic anemia in the world Sickle cell anemia is the prototypical (and most prevalent) hemoglobinopathy Mutation in the β-globin

More information

Rationale for RBC Transfusion in SCD

Rationale for RBC Transfusion in SCD Rationale for RBC Transfusion in SCD Dilution of HgbS-containing RBCs via the addition of HgbA-containing cells from the blood of normal donors Suppression of erythropoietin release caused by the rise

More information

Acute Complications of Sickle Cell Disease

Acute Complications of Sickle Cell Disease Management of Acute Complications of Sickle Cell Disease A Pocket Guide for the Clinician Timothy McCavit, MD, MSCS 1 Payal Desai, MD 1 University of Texas Southwestern Medical Center The Ohio State University,

More information

The Management of Acute Chest Syndrome in Children with Sickle Cell Disease

The Management of Acute Chest Syndrome in Children with Sickle Cell Disease The Management of Acute Chest Syndrome in Children with Sickle Cell Disease Document Information Version: 4 Date: Dec 2013 Authors (incl. job title): Professor David Rees and Dr Sue Height, consultant

More information

Third Visit Posttest

Third Visit Posttest Test code 03C Patient s name: Third Visit Posttest Patient s birth date: Your name and relationship to patient: Today s date: Please mark only one answer for each of the following questions: 1. Which one

More information

Hydroxyurea and Transfusion Therapy for the Treatment of Sickle Cell Disease

Hydroxyurea and Transfusion Therapy for the Treatment of Sickle Cell Disease Hydroxyurea and Transfusion Therapy for the Treatment of Sickle Cell Disease A Pocket Guide for the Clinician Susan E. Creary, MD, MSc 1 John J. Strouse, MD, PhD 2 1 The Ohio State University School of

More information

SICKLE CELL DISEASE. Dr. MUBARAK ABDELRAHMAN MD PEDIATRICS AND CHILD HEALTH. Assistant Professor FACULTY OF MEDICINE -JAZAN

SICKLE CELL DISEASE. Dr. MUBARAK ABDELRAHMAN MD PEDIATRICS AND CHILD HEALTH. Assistant Professor FACULTY OF MEDICINE -JAZAN SICKLE CELL DISEASE Dr. MUBARAK ABDELRAHMAN MD PEDIATRICS AND CHILD HEALTH Assistant Professor FACULTY OF MEDICINE -JAZAN Objective: The student should be able: To identify the presentation, diagnosis,

More information

Comprehensive Care for Children and Adolescents with Sickle Cell Diseases

Comprehensive Care for Children and Adolescents with Sickle Cell Diseases Comprehensive Care for Children and Adolescents with Sickle Cell Diseases Objectives To review the system for newborn screening of infants for sickling diseases To provide the framework for a comprehensive

More information

PART II: PREVENTING AND MANAGING COMPLICATIONS OF SICKLE CELL DISEASE

PART II: PREVENTING AND MANAGING COMPLICATIONS OF SICKLE CELL DISEASE PART II: PREVENTING AND MANAGING COMPLICATIONS OF SICKLE CELL DISEASE 1. PAIN Principles To educate patients, family and other caregivers about prevention, rapid identification and management of vaso-occlusive

More information

Family Centered Pediatric Emergency Department Sickle Cell Assessment of Needs and Strengths (FC-Peds-ED-SCANS) Overall Algorithm

Family Centered Pediatric Emergency Department Sickle Cell Assessment of Needs and Strengths (FC-Peds-ED-SCANS) Overall Algorithm Family Centered Pediatric Emergency Department Sickle Cell Assessment of Needs and Strengths (FC-Peds-ED-SCANS) Overall Algorithm Decision 1: Triage Decision 2: Analgesic Management Decision 3: Diagnostic

More information

MI Newborn Screening Program: An Overview of Follow-up & Case Management for Sickle Cell Conditions

MI Newborn Screening Program: An Overview of Follow-up & Case Management for Sickle Cell Conditions Michigan Department of Community Health MI Newborn Screening Program: An Overview of Follow-up & Case Management for Sickle Cell Conditions Dominic Smith, MSA - Linda Carter, BSW - Ben Frazier, BSW - Ruth

More information

DONE BY : RaSHA RAKAN & Bushra Saleem

DONE BY : RaSHA RAKAN & Bushra Saleem DONE BY : RaSHA RAKAN & Bushra Saleem Hemolytic anemias (2 of 2) Sickle Cell Anemia The most common familial hemolytic anemia in the world Sickle cell anemia is the prototypical (and most prevalent) hemoglobinopathy

More information

Sickle Cell Disease Patient Handbook

Sickle Cell Disease Patient Handbook Sickle Cell Disease Patient Handbook , Important Contact Information Office/Unit Phone Number: Outpatient Clinic: 708.684.3898 Make an appointment: 708.684.3113 Please leave a message and a receptionist

More information

Below are the sections of the DNA sequences of a normal hemoglobin gene and the mutated gene that causes sickle cell disease.

Below are the sections of the DNA sequences of a normal hemoglobin gene and the mutated gene that causes sickle cell disease. Sickle Cell Analysis Directions: Read the information below to complete the two tables. A person with sickle-cell disease has the genotype: Hb s Hb s. People who have this condition have two abnormal genes,

More information

Acute vaso-occlusive Pain in children

Acute vaso-occlusive Pain in children Acute vaso-occlusive Pain in children Dr François Angoulvant 1 Dr Sebastien Redant 2 Dr Malika Benkerrou 1 Pr Alina Ferster 2 Hôpital Robert Debré - Paris Hôpital des Enfants Reine Fabiola Bruxelles Réseau

More information

The Overlap Between Sickle Cell and Effective Chronic Disease Treatment and Management

The Overlap Between Sickle Cell and Effective Chronic Disease Treatment and Management The Overlap Between Sickle Cell and Effective Chronic Disease Treatment and Management Nirmish Shah, MD Assistant Professor Director of the Sickle Cell Transition Program Division of Pediatric Hematology/Oncology

More information

Hemoglobinopathies NORMAL HEMOGLOBINS

Hemoglobinopathies NORMAL HEMOGLOBINS Hemoglobinopathies Millicent Sutton MD October 28, 2005 NORMAL HEMOGLOBINS Consist of 2 alpha chains and 2 non alpha chains Hb A = α2β2 Hb F= α 2γ2 Hb A2 = α2δ2 1 Hemoglobin Variants Altered the conformational

More information

Sickle cell disease (SCD) and other hemoglobinopathies

Sickle cell disease (SCD) and other hemoglobinopathies Sickle cell disease (SCD) and other hemoglobinopathies You have received this leaflet, because your child has been diagnosed with sickle cell disease. We can imagine how overwhelming such a diagnosis must

More information

Peri-Operative Management: Guidelines for Inpatient Management of Children with Sickle Cell Disease

Peri-Operative Management: Guidelines for Inpatient Management of Children with Sickle Cell Disease Version 02 Approved by Interprofessional Patient Care Committee: September 16, 2016 1.0 Background Children with Sickle Cell are at risk of developing post-operative Acute Chest Syndrome. With improvements

More information

Acute Complications of Sickle Cell Disease Case Study 5 year old girl with Hemoglobin SS, weakness and slurred speech

Acute Complications of Sickle Cell Disease Case Study 5 year old girl with Hemoglobin SS, weakness and slurred speech Acute Complications of Sickle Cell Disease Case Study 5 year old girl with Hemoglobin SS, weakness and slurred speech Beatrice E. Gee, MD Medical Director, Sickle Cell and Hematology Program Children s

More information

Hematology/Oncology/BMT

Hematology/Oncology/BMT The University of Arizona Pediatric Residency Program Primary Goals for Rotation Hematology/Oncology/BMT 1. GOAL: Understand the role of the pediatrician in preventing hematologic or oncologic conditions,

More information

Aneurin Bevan University Health Board Sickle Cell Anaemia and Haemoglobinopathy Screening and Management in Pregnancy Guidelines

Aneurin Bevan University Health Board Sickle Cell Anaemia and Haemoglobinopathy Screening and Management in Pregnancy Guidelines Sickle Cell Anaemia and Haemoglobinopathy Screening and Management in Pregnancy Guidelines N.B. Staff should be discouraged from printing this document. This is to avoid the risk of out of date printed

More information

Blood and Marrow Transplant (BMT) for Sickle Cell Disease

Blood and Marrow Transplant (BMT) for Sickle Cell Disease Blood and Marrow Transplant (BMT) for Sickle Cell Disease Rhiannon is now cured of sickle cell disease after BMT. Blood and marrow transplant (BMT) is a proven cure for sickle cell disease. This handbook

More information

General Characterisctics

General Characterisctics Anemia General Characterisctics Definition: anemia is a decrease in red blood cells. Happens due to underproduction, increased destruction or loss of red cells. Diagnosis of anemia: Hgb < 135 (men) Hgb

More information

Community Acquired Pneumonia

Community Acquired Pneumonia April 2014 References: 1. Bradley JS, Byington CL, Shah SS, Alverson B, Carter ER, Harrison C, Kaplan SL Mace SE, McCracken Jr. GH, Moor MR, St. Peter SD, Stockwell JA, and Swanson JT. The Management of

More information

Introduction reduction in output alter the amino acid sequence combination

Introduction reduction in output alter the amino acid sequence combination Sickle cell anemia. Introduction Mutations in the globin genes can cause a quantitative reduction in output from that gene or alter the amino acid sequence of the protein produced or a combination of the

More information

Dr Banu Kaya Consultant Haematologist Barts Health NHS Trust Royal London Hospital, London, UK SICKLE CELL AND THALASSAEMIA OVERVIEW

Dr Banu Kaya Consultant Haematologist Barts Health NHS Trust Royal London Hospital, London, UK SICKLE CELL AND THALASSAEMIA OVERVIEW Dr Banu Kaya Consultant Haematologist Barts Health NHS Trust Royal London Hospital, London, UK SICKLE CELL AND THALASSAEMIA OVERVIEW Objectives Gain awareness of haemoglobinopathy inheritance, pathophysiology

More information

Medical and Surgical Complications of Sickle Cell Anemia

Medical and Surgical Complications of Sickle Cell Anemia Medical and Surgical Complications of Sickle Cell Anemia Ahmed Al-Salem Medical and Surgical Complications of Sickle Cell Anemia Ahmed Al-Salem Department of Surgery Dar A lalafia Medical Company Qatif

More information

Pediatric Red Cell Exchange Indications, Benefits, Barriers. View from California Saturday May 9 th ASFA 2015

Pediatric Red Cell Exchange Indications, Benefits, Barriers. View from California Saturday May 9 th ASFA 2015 Pediatric Red Cell Exchange Indications, Benefits, Barriers View from California Saturday May 9 th ASFA 2015 Red Cell Exchange: Not SCD Recommendations for Red Cell Exchange Indication Procedure Recommendation

More information

Biance Rowe Chris Hani Baragwanath Hospital Paediatric Haematology Oncology University of the Witwatersrand

Biance Rowe Chris Hani Baragwanath Hospital Paediatric Haematology Oncology University of the Witwatersrand Biance Rowe Chris Hani Baragwanath Hospital Paediatric Haematology Oncology University of the Witwatersrand SCD affects 20-25 million people globally 12-15 million in Africa 300 000 children with SCD

More information

Sickle Cell Disease: Myths and Realities. Marsha Treadwell, PhD Wanda Payton Williams, MS 6 August 2014

Sickle Cell Disease: Myths and Realities. Marsha Treadwell, PhD Wanda Payton Williams, MS 6 August 2014 Sickle Cell Disease: Myths and Realities Marsha Treadwell, PhD Wanda Payton Williams, MS 6 August 2014 Outline Who we are Sickle cell disease pathophysiology Sickle cell trait versus sickle cell disease

More information

CURRENT RESEARCH STUDIES

CURRENT RESEARCH STUDIES CURRENT RESEARCH STUDIES SCAGO SICKLE CELL RESEARCH DAY MAY 12, 2018 REBECCA LEROUX RN, BSCN, CCRP RED BLOOD CELL DISORDERS PROGRAM, UNIVERSITY HEALTH NETWORK MANUELA MERELLES-PULCINI RN, BSCN, MSN, CCRP

More information

Sickle Cell Anemia A Fictional Reconstruction Answer Key

Sickle Cell Anemia A Fictional Reconstruction Answer Key We have made it easy for you to find a PDF Ebooks without any digging. And by having access to our ebooks online or by storing it on your computer, you have convenient answers with sickle cell anemia a

More information

Every day matters. To help you stay out of the hospital, you can: Live healthy with sickle cell disease

Every day matters. To help you stay out of the hospital, you can: Live healthy with sickle cell disease Living with sickle cell disease (SCD) can be difficult. There can be severe pain and discomfort. AmeriHealth Caritas Louisiana wants to help you manage this life-threatening disease. To help you stay out

More information

1. Adequate diet and iron intake to prevent iron deficiency 2. Signs and symptoms of malignant disease

1. Adequate diet and iron intake to prevent iron deficiency 2. Signs and symptoms of malignant disease Hematology/Oncology Description: The pediatric hematology-oncology division sees a wide spectrum of pediatric disease including but not limited to leukemia, hemophilia, solid tumors, ITP, and other blood

More information

Hydroxyurea Treatment for Sickle Cell Disease

Hydroxyurea Treatment for Sickle Cell Disease Hydroxyurea Treatment for Sickle Cell Disease Before Hydroxyurea After Hydroxyurea Hydroxyurea Treatment for Sickle Cell Disease This document is not intended to take the place of the care and attention

More information

Other labs 4/24/2012. N 24: Pediatric Hematological Alterations & Cancer Intro. Cabrillo College ADN Program C. Madsen RN, MSN 1.

Other labs 4/24/2012. N 24: Pediatric Hematological Alterations & Cancer Intro. Cabrillo College ADN Program C. Madsen RN, MSN 1. Evaluation of CBC Evaluate type of WBCs Reticulocyte count RBC size, shape, color MCV: size RBC color (hypo or normo chromic) Mean corpuscular hemoglobin concentration (MCHC) Mean corpuscular hemoglobin

More information

Interleukin-1ß and Interleukin-6 Genetic Polymorphisms and Sickle Cell Disease: An Egyptian Study

Interleukin-1ß and Interleukin-6 Genetic Polymorphisms and Sickle Cell Disease: An Egyptian Study Interleukin-1ß and Interleukin-6 Genetic Polymorphisms and Sickle Cell Disease: An Egyptian Study MONA EL-GHAMRAWY, MD, PROFESSOR OF PEDIATRICS & PEDIATRIC HEMATOLOGY, CAIRO UNIVERSITY melghamrawy95@gmail.com

More information

More Efficient Exchange of Sickle Red Blood Cells can be Achieved by Exchanging the Densest Red Blood Cells

More Efficient Exchange of Sickle Red Blood Cells can be Achieved by Exchanging the Densest Red Blood Cells More Efficient Exchange of Sickle Red Blood Cells can be Achieved by Exchanging the Densest Red Blood Cells Thibodeaux, SR, Jamensky, L, Schell K, Irwin L, O Doherty U Hospital of the University of Pennsylvania

More information

Hydroxyurea in Pediatric Patients With Sickle Cell Disease: What Nurses Need to Know

Hydroxyurea in Pediatric Patients With Sickle Cell Disease: What Nurses Need to Know 614962JPOXXX10.1177/1043454215614962Journal of Pediatric Oncology NursingRees research-article2015 Article Hydroxyurea in Pediatric Patients With Sickle Cell Disease: What Nurses Need to Know Journal of

More information

Making Hope A Reality December 10, Nasdaq : BLUE

Making Hope A Reality December 10, Nasdaq : BLUE Making Hope A Reality December 10, 2014 Nasdaq : BLUE Forward Looking Statement These slides and the accompanying oral presentation contain forward-looking statements and information. The use of words

More information

DIC. Disseminated intravascular coagulation, is a life threatening pathological process in which clotting factors are abnormally activated.

DIC. Disseminated intravascular coagulation, is a life threatening pathological process in which clotting factors are abnormally activated. Miss. kamlah 1 DIC Disseminated intravascular coagulation, is a life threatening pathological process in which clotting factors are abnormally activated. Resulting in wide spread of clot formation in the

More information

Eighth Visit Posttest

Eighth Visit Posttest Test code 08B Patient s name: Eighth Visit Posttest Patient s birth date: Your name and relationship to patient: Today s date: Please mark only one answer for each of the following questions: 1. Which

More information

1 Kattamis et al. Growth of Children with Thalassemia: Effect of Different Transfusion Regimens. Archives of

1 Kattamis et al. Growth of Children with Thalassemia: Effect of Different Transfusion Regimens. Archives of Objectives Sickle Cell Anemia and Thalassemia: Transplantation Provide overview of hemoglobinopathies: Sickle cell disease and Thalassemia Discuss approaches to therapy Review recent registry collaboration

More information

Historic and Current Complications in Children with Sickle Cell Disease

Historic and Current Complications in Children with Sickle Cell Disease Historic and Current Complications in Children with Sickle Cell Disease Trish McMahon Peterson RN, MSN, CPNP Thomas C. Hofstra MD Children's Hospital Los Angeles Comprehensive Sickle Cell Program Children's

More information

Lessons in Management of Sickle Cell Disease. CME Conference, Lloyd Erskine Sandiford Centre, November 15, 2015

Lessons in Management of Sickle Cell Disease. CME Conference, Lloyd Erskine Sandiford Centre, November 15, 2015 Lessons in Management of Sickle Cell Disease CME Conference, Lloyd Erskine Sandiford Centre, November 15, 2015 Age at Death in African SS Disease The greatest chance of death is in the first is in the

More information

Bridging the Gap: Improving Sickle Cell Disease Transition from Pediatric- to Adult-Focused Care ASFA 2017 Annual Meeting

Bridging the Gap: Improving Sickle Cell Disease Transition from Pediatric- to Adult-Focused Care ASFA 2017 Annual Meeting Bridging the Gap: Improving Sickle Cell Disease Transition from Pediatric- to Adult-Focused Care ASFA 2017 Annual Meeting Kim Smith-Whitley, MD Director Comprehensive Sickle Cell Center The Children s

More information

Hospital Management of Sickle Cell Playing Fireman..

Hospital Management of Sickle Cell Playing Fireman.. Hospital Management of Sickle Cell Playing Fireman.. Brad Lewis SFGH bloods so mad, feels like coagulatin. Berry McGuire (Eve of Destruction) A pint of sweat will save a gallon of blood Gen. George Patton

More information

High Hemoglobin F in a Saudi Child Presenting with Pancytopenia

High Hemoglobin F in a Saudi Child Presenting with Pancytopenia Case Report imedpub Journals http://www.imedpub.com Journal of Pediatric Care ISSN 2471-805X DOI: 10.21767/2471-805X.100002 High Hemoglobin F in a Saudi Child Presenting with Pancytopenia Abstract Saudi

More information

TRANSFUSION PRACTICES IN THE MANAGEMENT OF SICKLE CELL DISEASE AMONG FLORIDA PHYSICIANS

TRANSFUSION PRACTICES IN THE MANAGEMENT OF SICKLE CELL DISEASE AMONG FLORIDA PHYSICIANS TRANSFUSION PRACTICES IN THE MANAGEMENT OF SICKLE CELL DISEASE AMONG FLORIDA PHYSICIANS By LEVETTE NICOLE DUNBAR A THESIS PRESENTED TO THE GRADUATE SCHOOL OF THE UNIVERSITY OF FLORIDA IN PARTIAL FULFILLMENT

More information

Instructor s Manual Chapter 26 Hematological Alterations. 1. A man and woman both test positive for the sickle cell trait. The couple asks the

Instructor s Manual Chapter 26 Hematological Alterations. 1. A man and woman both test positive for the sickle cell trait. The couple asks the 1 Instructor s Manual Chapter 26 Hematological Alterations Answers to Study Questions 1. A man and woman both test positive for the sickle cell trait. The couple asks the nurse how many of their children

More information

A Lawyer s Perspective on Genetic Screening Performed by Cryobanks

A Lawyer s Perspective on Genetic Screening Performed by Cryobanks A Lawyer s Perspective on Genetic Screening Performed by Cryobanks As a lawyer practicing in the area of sperm bank litigation, I have, unfortunately, represented too many couples that conceived a child

More information

Original Article:http://www.mayoclinic.com/health/sickle-cell-anemia/DS00324

Original Article:http://www.mayoclinic.com/health/sickle-cell-anemia/DS00324 1 Original Article:http://www.mayoclinic.com/health/sickle-cell-anemia/DS00324 Sickle Cell Anemia [Mayo Clinic Staff. Sickle cell anemia. MayoClinic.com; Mar 28, 2007: http://www.mayoclinic.com/health/sickle-cell-anemia/ds00324]

More information

Acute Chest Syndrome. Rationale for Red Blood Cell Exchange and/or Simple Transfusion Keith Quirolo, M.D. May 5th 2015 ASFA Annual Meeting

Acute Chest Syndrome. Rationale for Red Blood Cell Exchange and/or Simple Transfusion Keith Quirolo, M.D. May 5th 2015 ASFA Annual Meeting Acute Chest Syndrome Rationale for Red Blood Cell Exchange and/or Simple Transfusion Keith Quirolo, M.D. May 5th 2015 ASFA Annual Meeting Disclosure Consultant: Terumo BCT Discussion Etiology Pulmonary

More information

Newborn Screening and Followup for Hemoglobinopathies

Newborn Screening and Followup for Hemoglobinopathies Newborn Screening and Followup for Hemoglobinopathies October 4, 2012 Monica Hulbert, MD Director, Sickle Cell Disease Program Washington University School of Medicine St. Louis Children s Hospital Disclosures

More information

Regulatory Challenges in Apheresis Global Perspectives - Cell Therapy

Regulatory Challenges in Apheresis Global Perspectives - Cell Therapy Regulatory Challenges in Apheresis Global Perspectives - Cell Therapy Joseph (Yossi ) Schwartz, MD, MPH Director, Transfusion Medicine & Cellular Therapy Columbia University Medical Center New York Presbyterian

More information

Compassionate-use Experience With Voxelotor (GBT440) for Patients With Severe Sickle Cell Disease (SCD) and Life-Threatening Comorbidities

Compassionate-use Experience With Voxelotor (GBT440) for Patients With Severe Sickle Cell Disease (SCD) and Life-Threatening Comorbidities Compassionate-use Experience With Voxelotor (GBT440) for Patients With Severe Sickle Cell Disease (SCD) and Life-Threatening Comorbidities Gershwin Blyden, MD 1, Kenneth R. Bridges, MD 2, Lanetta Bronté,

More information

Sickle Cell Disease Integrated Care Models: Outpatient and Inpatient National Minority Quality Forum April 2017

Sickle Cell Disease Integrated Care Models: Outpatient and Inpatient National Minority Quality Forum April 2017 Sickle Cell Disease Integrated Care Models: Outpatient and Inpatient National Minority Quality Forum April 2017 Kim Smith-Whitley, MD Director Comprehensive Sickle Cell Center The Children s Hospital of

More information

Physician Orders ADULT: Sickle Cell Inpatient Plan

Physician Orders ADULT: Sickle Cell Inpatient Plan Initiate Orders Phase Care Sets/Protocols/PowerPlans Initiate Powerplan Phase Phase: Sickle Cell Inpatient Phase, When to Initiate: When patient arrives to unit Sickle Cell Inpatient Phase Admission/Transfer/Discharge

More information

Tenth Visit posttest

Tenth Visit posttest Test Code 10C Patient s name: Tenth Visit posttest Patient s birth date: Your name and relationship to patient: Today s date: 1. Which one of the medications listed below should every child with a sickle

More information

Gaining perspective on the spectrum of sickle cell anemia: Question: What do all these real life presentations have in common?

Gaining perspective on the spectrum of sickle cell anemia: Question: What do all these real life presentations have in common? Sickle-Cell Management Objectives: After reading this lecture the participant should be able to: 1. Explain the basic disease process of Sickle Cell Anemia 2. Have an understanding of the precipitants

More information

Blood Transfusion Guidelines in Clinical Practice

Blood Transfusion Guidelines in Clinical Practice Blood Transfusion Guidelines in Clinical Practice Salwa Hindawi Director of Blood Transfusion Services Associate Professor in Haematology and Transfusion Medicine King Abdalaziz University, Jeddah Saudi

More information

Health Maintenance and Education for Children and Adults

Health Maintenance and Education for Children and Adults Health Maintenance and Education for Children and Adults Richard Ward, MSc, MRCP, FRCPath Director, Red Blood Cell Disorders Program, UHN Assistant Professor, Hematology, University of Toronto Chair, Canadian

More information

Sickle Cell Disease and Stroke

Sickle Cell Disease and Stroke Sickle Cell Disease and Stroke You are the Power You are the Power You are the Power You are the Power You are the Power You are the Power You are the Power You are the Power You are the Power You are

More information

SCD Advocacy Talking Points!

SCD Advocacy Talking Points! "#$!%&'()*)+!,!-././-1!! SCD Advocacy Talking Points! * 23!4*'3!53*673&!84*8!#*59:(679*!#495&637;!9

More information

RBCs Disorders 1. Dr. Nabila Hamdi MD, PhD

RBCs Disorders 1. Dr. Nabila Hamdi MD, PhD RBCs Disorders 1 Dr. Nabila Hamdi MD, PhD ILOs Discuss the classification of anemia into hypochromic-microcytic, normochromicnormocytic and macrocytic. Categorize laboratory test procedures used in the

More information

Genetics of Thalassemia

Genetics of Thalassemia Genetics of Thalassemia Submitted by : Raya Samir Al- Hayaly Sura Zuhair Salih Saad Ghassan Al- Dulaimy Saad Farouq Kassir Sama Naal Salouha Zahraa Jasim Al- Aarajy Supervised by : Dr. Kawkab Adris Mahmod

More information

Hydroxyurea Treatment for Sickle Cell Disease

Hydroxyurea Treatment for Sickle Cell Disease Hydroxyurea Treatment for Sickle Cell Disease Hydroxyurea Treatment for Sickle Cell Disease 1 This document is not intended to take the place of the care and attention of your personal physician. Our aim

More information

Wiskott-Aldrich Syndrome

Wiskott-Aldrich Syndrome chapter 7 Wiskott-Aldrich Syndrome Wiskott-Aldrich syndrome is a primary immunodeficiency disease involving both T- and B-lymphocytes. In addition, the blood cells that help control bleeding, called platelets

More information

USAID Health Care Improvement Project. pneumonia) respiratory infections through improved case management (amb/hosp)

USAID Health Care Improvement Project. pneumonia) respiratory infections through improved case management (amb/hosp) Improvement objective: : decrease morbidity and mortality due to acute upper (rhinitis, sinusitis, pharyngitis) and lower (bronchitis, pneumonia) respiratory infections through improved case management

More information

Achieving a Better Understanding of the Impact of Sickle Cell in Indiana CHeP Pilot Project Symposium Gary Gibson Monica Khurana Marc Rosenman

Achieving a Better Understanding of the Impact of Sickle Cell in Indiana CHeP Pilot Project Symposium Gary Gibson Monica Khurana Marc Rosenman Achieving a Better Understanding of the Impact of Sickle Cell in Indiana 2017 CHeP Pilot Project Symposium Gary Gibson Monica Khurana Marc Rosenman Primary Aims of Project Obtain much-needed estimates

More information

Sickle Cell Disease. WHAT IS SICKLE CELL DISEASE? Hemoglobin and the Sickle Cell Disease Process

Sickle Cell Disease. WHAT IS SICKLE CELL DISEASE? Hemoglobin and the Sickle Cell Disease Process Sickle Cell Disease WHAT IS SICKLE CELL DISEASE? Hemoglobin and the Sickle Cell Disease Process Hemoglobin is a complex molecule and the most important component of red blood cells. [For a description

More information

Fever in the Newborn Period

Fever in the Newborn Period Fever in the Newborn Period 1. Definitions 1 2. Overview 1 3. History and Physical Examination 2 4. Fever in Infants Less than 3 Months Old 2 a. Table 1: Rochester criteria for low risk infants 3 5. Fever

More information

Newborn Screening for Sickle Cell Disease in Africa: Public health meets reality

Newborn Screening for Sickle Cell Disease in Africa: Public health meets reality 13 th September 2016 Newborn Screening for Sickle Cell Disease in Africa: Public health meets reality Kwaku Ohene-Frempong. MD Children s Hospital of Philadelphia Sickle Cell Foundation of Ghana Disclosure

More information

The McMaster at night Pediatric Curriculum

The McMaster at night Pediatric Curriculum The McMaster at night Pediatric Curriculum Community Acquired Pneumonia Based on CPS Practice Point Pneumonia in healthy Canadian children and youth and the British Thoracic Society Guidelines on CAP Objectives

More information

Extra Notes 3. Warm. In the core (center) of the body, where the temperature is 37 C.

Extra Notes 3. Warm. In the core (center) of the body, where the temperature is 37 C. Extra Notes 3 *The numbers of the slides are according to the last year slides. Slide 33 Autoimmune hemolytic anemia : Abnormal circulating antibodies that target normal antigen on the RBC and cause lysis.

More information

Emergency Medical Training Services Emergency Medical Technician Paramedic Program Outlines Outline Topic: HEMATOLOGY Revised: 11/2013

Emergency Medical Training Services Emergency Medical Technician Paramedic Program Outlines Outline Topic: HEMATOLOGY Revised: 11/2013 Emergency Medical Training Services Emergency Medical Technician Paramedic Program Outlines Outline Topic: HEMATOLOGY Revised: 11/2013 What type of tissue is blood? Blood is considered liquid connective

More information

Quiz. What percentage of the world s population is a carrier of a hemoglobinopathy? Hemoglobinopathies in Pregnancy 1-2% 5-7% 8-12% 10-15%

Quiz. What percentage of the world s population is a carrier of a hemoglobinopathy? Hemoglobinopathies in Pregnancy 1-2% 5-7% 8-12% 10-15% Hemoglobinopathies in Pregnancy Emily Parkhurst, MS, LCGC Kaiser West Los Angeles November 2017 Genetics Department Quiz What percentage of the world s population is a carrier of a hemoglobinopathy? 1-2%

More information

Your sickle cell disease story

Your sickle cell disease story YOUR STORY Not actual patients. Your sickle cell disease story From the very beginning of sickle cell disease (SCD) to your role in the next chapter Visit GenSickleCell.com to get involved with the movement.

More information